Itau Unibanco Holding S.A.’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,071
Closed -$188K 746
2019
Q4
$188K Buy
+5,071
New +$181K 0.01% 272

Other funds holding PFE

Itau Unibanco Holding S.A.'s PFE Position: Q1 2026 in Review

Itau Unibanco Holding S.A. increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $2.18K and bringing the position to 2,442 shares worth $68.6K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

Itau Unibanco Holding S.A. first reported a position in PFE in Q1 2017 and has held it in 28 quarters since. The position peaked at $13.3M in Q4 2024. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Itau Unibanco Holding S.A. held 2,442 shares of Pfizer worth $68.6K as of Q1 2026.
  • Itau Unibanco Holding S.A. bought 82 Pfizer shares in Q1 2026, an estimated $2.18K.
  • Pfizer made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q1 2026, its #222 holding.
  • Itau Unibanco Holding S.A. first reported a position in Pfizer in Q1 2017 and has held it in 28 quarters since.
  • Itau Unibanco Holding S.A.'s Pfizer position peaked at $13.3M in Q4 2024.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2026, filed 14 May 2026.